Related Experiment Video
Updated: Jun 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Immune mechanisms involved in cardiovascular complications of chronic kidney disease
Andréa E M Stinghen1, Sergio Bucharles, Miguel C Riella
1Center for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Insights
Chronic inflammation in chronic kidney disease (CKD) drives complications like atherosclerosis and heart dysfunction. Modulating the immune response offers a promising intervention to reduce mortality in CKD patients.
Area of Science:
- Nephrology
- Immunology
- Cardiology
Background:
- Chronic inflammation is a hallmark of chronic kidney disease (CKD).
- This sustained inflammation contributes to major CKD complications, including vascular degeneration, myocardial fibrosis, and heart dysfunction.
- Immune-mediated consequences of uremic toxicity are critical for risk stratification and understanding disease mechanisms.
Purpose of the Study:
- To review the immune mechanisms underlying atherosclerosis and myocardiopathy in CKD.
- To highlight emerging evidence on immune-modulating strategies for CKD patients.
Main Methods:
- Literature review focusing on immune mechanisms in CKD.
- Synthesis of recent evidence on inflammation, atherosclerosis, and myocardiopathy in CKD.
- Discussion of potential therapeutic strategies targeting immune pathways.
Main Results:
- Chronic inflammation exacerbates atherosclerosis and myocardial fibrosis in CKD.
- Uremic toxins trigger immune responses that accelerate vascular calcification and cardiac dysfunction.
- Immune-mediated pathways are key drivers of mortality in CKD.
Conclusions:
- Understanding immune mechanisms in CKD is crucial for developing targeted therapies.
- Strategies modulating the immune response or reducing inflammatory triggers may reduce mortality.
- Further research is needed to translate these findings into clinical practice for CKD management.
Abstract:
A sustained status of chronic inflammation is closely linked to several complications of chronic kidney disease (CKD), such as vascular degeneration, myocardial fibrosis, loss of appetite, insulin resistance, increased muscle catabolism and anemia. These consequences of a chronically activated immune system impact on the acceleration of atherosclerosis, vascular calcification and development of heart dysfunction. Recent evidence suggests that these immune-mediated consequences of uremic toxicity are not only important to stratify the risk and understand the mechanisms of disease, but also represent an important area for intervention. Thus, the aim of this brief review is to discuss the immune mechanisms behind atherosclerosis and myocardiopathy in CKD. We also display the emerging evidence that strategies focusing on modulating the immune response or reducing the generation of triggers of inflammation may represent an important tool to reduce mortality in this group of patients. Ongoing studies may generate the evidence that will translate these strategies to definitive changes in clinical practice.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Heart Failure Drugs: Diuretics
